Sarah Cannon Research Institute at HealthONE - SCRI - PPDS — Denver, Colorado

Sarah Cannon Research Institute at HealthONE - SCRI - PPDS is a clinical research site located in Denver, Colorado, United States 80218.

Crixeo Health Trust Score: 47/100 (POOR). This profile has not yet been claimed by the site owner.

Sarah Cannon Research Institute at HealthONE - SCRI - PPDS has participated in 1 clinical trials.

Therapeutic areas: Malignant Melanoma, Melanoma, Metastatic Melanoma.

Sponsors: Pfizer.

Sponsor Feasibility Report

Trust Score: 47/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sarah Cannon Research Institute at HealthONE - SCRI - PPDS?

Sarah Cannon Research Institute at HealthONE - SCRI - PPDS has a Crixeo Trust Score of 47/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sarah Cannon Research Institute at HealthONE - SCRI - PPDS conducted?

Sarah Cannon Research Institute at HealthONE - SCRI - PPDS has 1 clinical trials on record. Their work covers Malignant Melanoma, Melanoma, Metastatic Melanoma.

Is Sarah Cannon Research Institute at HealthONE - SCRI - PPDS accredited by Crixeo Health?

Sarah Cannon Research Institute at HealthONE - SCRI - PPDS has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Sarah Cannon Research Institute at HealthONE - SCRI - PPDS?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.